Medical - Devices
Compare Stocks
2 / 10Stock Comparison
EDAP vs IRTC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
EDAP vs IRTC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Medical - Devices |
| Market Cap | $156M | $4.10B |
| Revenue (TTM) | $70M | $788M |
| Net Income (TTM) | $-13M | $-28M |
| Gross Margin | 46.8% | 71.0% |
| Operating Margin | -38.2% | -3.3% |
| Total Debt | $28M | $731M |
| Cash & Equiv. | $17M | $236M |
EDAP vs IRTC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Edap Tms S.a. (EDAP) | 100 | 154.1 | +54.1% |
| iRhythm Technologie… (IRTC) | 100 | 100.5 | +0.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EDAP vs IRTC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EDAP is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.77
- Lower volatility, beta 0.77, current ratio 1.54x
- Beta 0.77, current ratio 1.54x
IRTC carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 26.2%, EPS growth 61.7%, 3Y rev CAGR 22.1%
- 379.3% 10Y total return vs EDAP's 18.9%
- 26.2% revenue growth vs EDAP's 10.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.2% revenue growth vs EDAP's 10.3% | |
| Quality / Margins | -3.5% margin vs EDAP's -18.9% | |
| Stability / Safety | Beta 0.77 vs IRTC's 0.93, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +80.9% vs IRTC's -8.3% | |
| Efficiency (ROA) | -2.8% ROA vs EDAP's -18.8%, ROIC -5.2% vs -69.2% |
EDAP vs IRTC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EDAP vs IRTC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
IRTC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IRTC is the larger business by revenue, generating $788M annually — 11.3x EDAP's $70M. IRTC is the more profitable business, keeping -3.5% of every revenue dollar as net income compared to EDAP's -18.9%. On growth, EDAP holds the edge at +31.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $70M | $788M |
| EBITDAEarnings before interest/tax | -$24M | -$6M |
| Net IncomeAfter-tax profit | -$13M | -$28M |
| Free Cash FlowCash after capex | -$17M | $19M |
| Gross MarginGross profit ÷ Revenue | +46.8% | +71.0% |
| Operating MarginEBIT ÷ Revenue | -38.2% | -3.3% |
| Net MarginNet income ÷ Revenue | -18.9% | -3.5% |
| FCF MarginFCF ÷ Revenue | -25.1% | +2.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +31.4% | +25.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.3% | +55.7% |
Valuation Metrics
EDAP leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $156M | $4.1B |
| Enterprise ValueMkt cap + debt − cash | $166M | $4.6B |
| Trailing P/EPrice ÷ TTM EPS | -5.33x | -89.83x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 2.20x | 5.49x |
| Price / BookPrice ÷ Book value/share | 8.02x | 26.16x |
| Price / FCFMarket cap ÷ FCF | — | 118.84x |
Profitability & Efficiency
IRTC leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
IRTC delivers a -20.6% return on equity — every $100 of shareholder capital generates $-21 in annual profit, vs $-65 for EDAP. EDAP carries lower financial leverage with a 1.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRTC's 4.79x. On the Piotroski fundamental quality scale (0–9), IRTC scores 6/9 vs EDAP's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -65.4% | -20.6% |
| ROA (TTM)Return on assets | -18.8% | -2.8% |
| ROICReturn on invested capital | -69.2% | -5.2% |
| ROCEReturn on capital employed | -56.0% | -4.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 |
| Debt / EquityFinancial leverage | 1.43x | 4.79x |
| Net DebtTotal debt minus cash | $10M | $495M |
| Cash & Equiv.Liquid assets | $17M | $236M |
| Total DebtShort + long-term debt | $28M | $731M |
| Interest CoverageEBIT ÷ Interest expense | -16.21x | -1.48x |
Total Returns (Dividends Reinvested)
IRTC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IRTC five years ago would be worth $15,609 today (with dividends reinvested), compared to $6,218 for EDAP. Over the past 12 months, EDAP leads with a +80.9% total return vs IRTC's -8.3%. The 3-year compound annual growth rate (CAGR) favors IRTC at -0.7% vs EDAP's -28.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +22.4% | -28.7% |
| 1-Year ReturnPast 12 months | +80.9% | -8.3% |
| 3-Year ReturnCumulative with dividends | -63.3% | -2.1% |
| 5-Year ReturnCumulative with dividends | -37.8% | +56.1% |
| 10-Year ReturnCumulative with dividends | +18.9% | +379.3% |
| CAGR (3Y)Annualised 3-year return | -28.4% | -0.7% |
Risk & Volatility
EDAP leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EDAP is the less volatile stock with a 0.77 beta — it tends to amplify market swings less than IRTC's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EDAP currently trades 82.4% from its 52-week high vs IRTC's 58.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.77x | 0.93x |
| 52-Week HighHighest price in past year | $5.05 | $212.00 |
| 52-Week LowLowest price in past year | $1.21 | $112.31 |
| % of 52W HighCurrent price vs 52-week peak | +82.4% | +58.9% |
| RSI (14)Momentum oscillator 0–100 | 54.8 | 44.1 |
| Avg Volume (50D)Average daily shares traded | 38K | 524K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates EDAP as "Buy" and IRTC as "Buy". Consensus price targets imply 55.1% upside for IRTC (target: $194) vs 44.2% for EDAP (target: $6).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $6.00 | $193.67 |
| # AnalystsCovering analysts | 8 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
IRTC leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EDAP leads in 2 (Valuation Metrics, Risk & Volatility).
EDAP vs IRTC: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is EDAP or IRTC a better buy right now?
For growth investors, iRhythm Technologies, Inc.
(IRTC) is the stronger pick with 26. 2% revenue growth year-over-year, versus 10. 3% for Edap Tms S. a. (EDAP). Analysts rate Edap Tms S. a. (EDAP) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — EDAP or IRTC?
Over the past 5 years, iRhythm Technologies, Inc.
(IRTC) delivered a total return of +56. 1%, compared to -37. 8% for Edap Tms S. a. (EDAP). Over 10 years, the gap is even starker: IRTC returned +379. 3% versus EDAP's +18. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — EDAP or IRTC?
By beta (market sensitivity over 5 years), Edap Tms S.
a. (EDAP) is the lower-risk stock at 0. 77β versus iRhythm Technologies, Inc. 's 0. 93β — meaning IRTC is approximately 22% more volatile than EDAP relative to the S&P 500. On balance sheet safety, Edap Tms S. a. (EDAP) carries a lower debt/equity ratio of 143% versus 5% for iRhythm Technologies, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — EDAP or IRTC?
By revenue growth (latest reported year), iRhythm Technologies, Inc.
(IRTC) is pulling ahead at 26. 2% versus 10. 3% for Edap Tms S. a. (EDAP). On earnings-per-share growth, the picture is similar: iRhythm Technologies, Inc. grew EPS 61. 7% year-over-year, compared to -52. 9% for Edap Tms S. a.. Over a 3-year CAGR, IRTC leads at 22. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — EDAP or IRTC?
iRhythm Technologies, Inc.
(IRTC) is the more profitable company, earning -6. 0% net margin versus -41. 5% for Edap Tms S. a. — meaning it keeps -6. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRTC leads at -4. 9% versus -35. 6% for EDAP. At the gross margin level — before operating expenses — IRTC leads at 70. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — EDAP or IRTC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is EDAP or IRTC better for a retirement portfolio?
For long-horizon retirement investors, iRhythm Technologies, Inc.
(IRTC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), +379. 3% 10Y return). Both have compounded well over 10 years (IRTC: +379. 3%, EDAP: +18. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between EDAP and IRTC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EDAP is a small-cap quality compounder stock; IRTC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.